Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm

Advances in Nursing Science

Volumn 28, Issue 4, 2005, Pages 320-332

  McCain, Nancy L ^a   Gray, Dorothy Patricia ^a   Walter, Jeanne M ^a   Robins, Jolynne ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cancer; Health; HIV; Physiology; Psychoneuroimmunology; Theory development

Indexed keywords

EID: 28044458743     PISSN: 01619268     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012272-200510000-00004     Document Type: Article

References (52)

1. McCain NL, Zeller JM. Psychoneuroimmunological studies in HIV disease. Ann Rev Nurs Research. 1996;14:23-55.
2. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer: 1984.
3. Byrnes DM, Antoni MH, Goodkin K, et al. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV+ black women at risk for cervical cancer. Psychosom Med. 1998;60:714-722.
4. Folkman S. Psychosocial effects of HIV infection. In: Goldberger L, Breznitz S, eds. Handbook of Stress: Theoretical and Clinical Aspects. 2nd ed. New York: Free Press: 1993:658-681.
5. Besedovsky HO, Del Rey A. Cytokines as mediators of central and peripheral immune-neuroendocrine interactions. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. Vol 1. 3rd ed. San Diego: Academic Press: 2001:1-17.
6. Ader R. Historical perspectives on psychoneuroimmunology. In: Friedman H, Klein T, Friedman AL, eds. Psychoneuroimmunology, Stress and Infection. Boca Raton, Fla: CRC Press: 1996:1-24.
7. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5:243-251.
8. Dhabhar FS, McEwen BS. Bi-directional effects of stress and glucocorticoid hormones on immune function: possible explanations for paradoxical observations. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. Vol 2. 3rd ed. San Diego, Calif: Academic Press; 2001:301-338.
9. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction Iκ B synthesis. Science. 1995;270:286-290.
10. Clerici M, Trabattoni D, Piconi S, et al. A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology. 1997;22(suppl 1):S27-S31.
11. + lymphocytes by inhibiting IL-12 production. J Immunol. 1998;160:2231-2237.
12. Larson SJ, Dunn AJ. Behavioral effects of cytokines. Brain Behave Immun. 2001;15:371-387.
13. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol. 2002;70:537-547.
14. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53:865-871.
15. Drolet G, Dumont EC, Gosselin I, Kindead R, LaForst S, Trottier JF. Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol. 2001;25:729-741.
16. Heijnen CJ, Kavelaars K. Opioid peptide production by the immune system. In: Schedlowski M, Tewes U, eds. Psychoneuroimmunology: An Interdisciplinary Introduction. New York: Plenum; 1999:209-222.
17. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601-630.
18. Tuck I. Development of a spirituality intervention to promote healing. J Theory Constr Test. 2004;8:67-71.
19. Wolf SL, Coogler C, Xu I. Exploring the basis for Tai Chi Chuan as a therapeutic exercise approach. Arch Phys Med Rehabil. 1997;78:886-892.
20. Astin JA. Stress reduction through mindfulness meditation: effects on psychological symptomatology, sense of control and spiritual experiences. Psychother Psychosom. 1997;66:97-106.
21. McCain NL, Munjas BA, Munro CL, et al. Effects of stress management on PNI-based outcomes in persons with HIV disease. Res Nurs Health. 2003;26:102-117.
22. McCain NL, Tuck I, Robins J, et al. Alternative stress management intervention reduces distress and symptomatology and enhances quality of life in persons with HIV disease [abstract]. Int J Behav Med. 2004;11(suppl):331.
23. Pitzalis C, Pipitone N, Bajocchi G, et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol. 1997;158:5007-5016.
24. Rosenburg YJ, Anderson AO, Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol Today. 1998;19:10-17.
25. Romagnani S, DelPrete G, Manetti R, et al. Role of TH1/TH2 cytokines in HIV infection. Immunol Rev. 1994;140:73-92.
26. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993;57:183-289.
27. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med. 1990;172:151-158.
28. Evans DL, Leserman J, Perkins DO, et al. Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection. Am J Psychiatry. 1995;152:543-550.
29. Gray DP, Robins JW, McCain NL. Viewing PNI from a qualitative perspective: stress and coping in HIV disease [abstract]. Brain Behav Immun. 2001;15:152-153.
30. Gray DP, McCain N, Tuck I, et al. Qualitative data contextualize findings of spirituality intervention designed to reduce stress and enhance coping in people with HIV infection [abstract published electronically] . Brain Behav Immun. 2004:18(3).
31. Cole SW, Kemeny ME. Psychobiology of HIV infection. Crit Rev Neurobiol. 1997;11:289-321.
32. Roux G, Bush H, Dingley C. Inner strength in women with breast cancer. J Theory Constr Test. 2001;5:19-27.
33. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol. 1995;7:704-710.
34. Igney FH, Behrens CK, Krammer PH. Tumor counterattack - Concept and reality. Eur J Immunol. 2000;30:725-731.
35. Salih HR, Nussler V. Immune escape versus tumor tolerance: how do tumors evade immune surveillance? Eur J Med Res. 2001;6:323-332.
36. Cohen M, Klein E, Kuten A, Fried G, Zinder O, Pollack S. Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines. Int J Cancer. 2002;100:347-354.
37. Whiteside TL. Measurement of NK-cell activity in humans. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical Laboratory Immunology. 6th ed. Washington: ASM Press; 2002:296-300.
38. Anderson BL, Farrar WB, Golden-Kreutz D, et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 1998;90:30-36.
39. Garland M, Doherty D, Golden-Mason L, Fitzpatrick P, Walsh N, O'Farrelly C. Stress-related hormonal suppression of natural killer activity does not show menstrual cycle variations: implications for timing of surgery for breast cancer. Anticancer Res. 2003;3B:2531-2535.
40. Block KI, Boyd DB, Gonzalez N, Vojdani A. The immune system in cancer. Integr Cancer Ther. 2002;1:294-316.
41. Larson MR, Duberstein PR, Talbot NL, Caldwell C, Moynihan JA. A presurgical psychosocial intervention for breast cancer patients. J Psychosom Res. 2000;2:187-194.
42. Matthews A, Ridgeway V, Warren R, Britton P. Predicting worry following a diagnosis of breast cancer. Psychooncology. 2002;5:415-418.
43. Kogon MM, Biswas A, Pearl D, Carlson RW, Spiegel D. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer. 1997;80:225-230.
44. Levy SM, Herberman RB, Lippman M, D'Angelo T, Lee J. Immunological and psychological predictors of disease recurrence in women with early-stage breast cancer. Behav Med. 1991;2:67-75.
45. Folkman S. Positive psychological states and coping with severe stress. Soc Sci Med. 1997;45:1207-1221.
46. Antoni MH, Lehman JM, Kilbourn, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001;20:20-32.
47. Folkman S, Moskowitz JT. Positive affect and the other side of coping. Am Psychol. 2000;55:647-654.
48. Ironson G, Solomon G, Balbin E, et al. The IronsonWoods Spirituality/Religiousness Index is associated with long survival, health behaviors, less distress, and low cortisol in people with HIV/AIDS. Ann Behav Med. 2002;24:34-48.
49. Burkhardt MA. Spirituality: an analysis of the concept. Holist Nurs Pract. 1989;3:69-77.
50. Burkhardt MA, Nagai-Jacobson MG. Spirituality and health. In: Dossey BM, Keagan L, Gauzzetta CE, eds. Holistic Nursing: A Handbook for Practice. Gaithersburg, Md: Aspen; 2000:91-122.
51. Levy SM, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med. 1990;52:73-85.
52. Turner-Cobb JM, Sephton SE, Speigel D. Psychosocial effects on immune function and disease progression in cancer: human studies. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. Vol 1. 3rd ed. San Diego, Calif: Academic Press: 2001:565-582.